OMX30 1 567 -0,9%  OMXH25 3 933 -0,9%  OMXC20 987 -1,3%  Dow 21 513 -0,3%  Nas 5 941 0,3%  EUR 9,5666 0,0%  USD 8,2208 0,0%  Olja 48,7 1,6%  Guld 1 255 -0,6% 

Ypsomed Aktie

137,20CHF 2,20CHF 1,63%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Ypsomed

2017 2018e 2019e 2020e 2021e
Utdelning 1,20 1,13 1,36 1,90 -
Direktavkastning (i %) 0,63 0,84 1,01 1,40 -
PE-tal 51,55 33,12 28,11 20,44 23,98
Resultat/aktie 3,67 4,08 4,80 6,60 5,63

Nyheter om Ypsomed AG

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Ypsomed AG

ytterligare analyser

Ypsomed Peer Group

Ypsomed 137,20
1,6%
pagehit

Lägg till instrument

Vad tycker du?

Profil Ypsomed AGtill bolagsprofilen

Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. Its products include DiaExpert, BGMS, OmniPod, YpsoPump & Orbit, Pen needles, Injection systems, and Contract manufacturing. The company operates through the following business segments: Diabetes Direct Business, Delivery Devices, Products, Ypsomed Diabetes Care, Ypsomed Delivery Systems. The Delivery Devices segment consists of business with the product group's pen systems, pen needles, infusion sets and other injection molded parts that are developed and manufactured by company. The Diabetes Direct Business segment consists of the sales and direct trade business with various supplies for diabetes care, for example, devices for the self-monitoring of blood glucose levels as well as infusion pumps, accessories and other day-to-day items for diabetics. The Ypsomed Diabetes Care segment owns, manufactures and trade products are marketed under the brand mylife Diabetescare directly to hospitals, physicians, pharmacies and patients via Ypsomed's subsidiaries and distributors. The Ypsomed Delivery Systems segment concerns B2B business and is directly managed by the company. Ypsomed Holding was founded by Wilhelm Michel on December 29, 2003 and is headquartered in Burgdorf, Switzerland.

Realtidskurs Ypsomed AG

Bid 124,12 EUR Ask 126,74 EUR
Kurstid 15:32 Börsen STU

Aktiekurs Ypsomed AG i CHFPUSH CHART

Kurs 137,20 CHF 2,20 1,63 %
Kurstid 17:31:06
Datum 24.07.2017
Öppning 144,00
Gårdagen 135,00
Dagshögsta 144,20
Dagslägsta 136,30
52 v. högsta 228,70
52 v. lägsta 132,50
52 v. perf.
Volym (Antal) 394 229
Börsvärde (SEK) 15,36 Mrd
Börsen
Kurs för 137,20 CHF från börsen SIX Swiss Exchange motsvarar med aktuell växelkurssentspricht CHF/SEK en kurs på 1 190,54 SEK.

Till aktien Ypsomed

Ticker
ISIN CH0019396990
Index SPI, BIRW - Bern Börse Index

Ypsomed Nyckeltal

Börsvärde i SEK 15,36 Mrd
Free float % 27,23
Antal aktier mio. 12,65
Cashflow/aktie i lokal valuta 6,15
Bokvärde/aktie i lokal valuta 23,93
60 dagar vola 33,23
PBV 7,91

Ypsomed Historiska kurser

2017-07-24 137,20 394 229
2017-07-21 135,00 708 123
2017-07-20 190,10 41 687
2017-07-19 190,80 47 442
2017-07-18 192,20 45 665